 |
|
|
|
|
|
|
|
 |
Results for 'Merck & Co Inc - Deals and Alliances Report' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Merck & Co. Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
100 % |
Merck KGaA Deals
Partneringdesk briefing
|
July 2005 |
£215 |
50 % |
Merck & Co Inc Deals
Partneringdesk briefing
|
July 2005 |
£215 |
47.5 % |
Partneringdesk deals and alliances in metabolic diseases
|
April 2006 |
£1250 |
39.5 % |
Partneringdesk deals and alliances in autoimmune & inflammatory diseases
|
April 2006 |
£1250 |
39 % |
Partneringdesk deals and alliances in infectious diseases
|
April 2006 |
£1250 |
39 % |
Effective Licensing & Commercialisation of Drug Delivery Systems
2006
|
July 2006 |
£2500 |
35 % |
Distribution Agreements in Biopharma
|
April 2008 |
£1195 |
32.2 % |
Merck & Co Inc -Detailed Product Pipeline
|
February 2008 |
£375 |
32 % |
Johnson & Johnson Deals
Partneringdesk briefing
|
July 2005 |
£215 |
32 % |
Co-promotion & Co-marketing Agreements in Biopharma
|
January 2008 |
£1195 |
31.85 % |
Manufacturing & Supply Agreements in Biopharma
|
April 2008 |
£1195 |
30.1 % |
Merger & Acquisition Agreements in Biopharma
|
February 2008 |
£1195 |
28 % |
Partneringreview 2006 – Deal Type
Volume 5
|
February 2006 |
£1395 |
25 % |
Partneringreview 2006 – Stage of Development
Volume 4
|
February 2006 |
£1395 |
25 % |
Partneringreview 2006 – Industry Sector
Volume 6
|
February 2006 |
£1395 |
25 % |
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends
|
November 2007 |
£7600 |
24.85 % |
Partneringreview 2006 – Therapy Area
Volume 2
|
February 2006 |
£1395 |
24.5 % |
Partneringreview 2006
|
February 2006 |
£2195 |
24.5 % |
Partneringreview 2006 - Company Deal Index
Volume 1
|
February 2006 |
£1395 |
24 % |
Partneringreview 2006 – Financings
Volume 3
|
February 2006 |
£1395 |
24 % |
Mylan Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
22 % |
Mylan Laboratories Generics Company Intelligence Report
|
June 2008 |
£195 |
21.5 % |
Opportunities and Challenges for Generic Drugs in the UK 2007
|
June 2007 |
£795 |
20.65 % |
The Top 10 Generics Companies
Strategic insight, growth opportunities and competitive dynamics in the US and Europe
|
January 2006 |
£1495 |
20.65 % |
Strategies for Innovation in Pharmaceutical R&D
Enhancing R&D Through Biotech Alliances and CRO Outsourcing
|
March 2005 |
£370 |
19.95 % |
Dr Reddy Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
18 % |
Commercial and Pipeline Perspectives Obesity
Lack of Reimbursement Limits Market Potential
|
November 2007 |
£2000 |
17.85 % |
Global Generics Guide
Benchmarking the key players
|
April 2006 |
£4000 |
17.5 % |
Pharmaceutical Distribution in Europe
The Emergence of Direct-to-Pharmacy Supply
|
February 2008 |
£995 |
15.5 % |
Dynavax Technologies Corp: Premium Company Profile
|
February 2008 |
£265 |
14.5 % |
The Vaccines 2008
World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
|
April 2008 |
£2070 |
13.65 % |
Aspen Pharmacare Generics Company Intelligence Report
Company Intelligence Report
|
June 2008 |
£195 |
13.5 % |
Product Lifecycle Management, 2006
|
May 2006 |
£1499 |
13.3 % |
Pharmaceutical Parallel Trade in the United Kingdom, 2000-2006
Market Insights and Trends in a Primary Import Destination
|
August 2006 |
£900 |
13 % |
Regional Volume I: Europe
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2007
|
July 2007 |
£195 |
12 % |
Pipeline Insight Asthma/COPD/Allergic Rhinitis
As Patents Expire, Novel Combinations Inspire
|
April 2005 |
£6000 |
11.9 % |
Generic Option; The
|
July 2006 |
£440 |
11.55 % |
Indian Pharmaceutical Industry, The:
|
March 2005 |
£3335 |
11.2 % |
Vaccines: The World Market
|
February 2007 |
£2015 |
11.2 % |
Vaccines
The World Market
|
February 2007 |
£2015 |
11.2 % |
World Market for Vaccines, The
|
November 2004 |
£2015 |
11.2 % |
Ranbaxy Generics Company Intelligence Report
Company Intelligence Report
|
June 2008 |
£195 |
11.2 % |
Ion Channel Drug Discovery
Therapeutic Opportunities & Technology Progress
|
May 2004 |
£680 |
11 % |
Global Market for Sleep-Wake Disorders, 2005-2012, The
Trends, Opportunities, and Insights in a High-Value CNS Therapy Area
|
December 2005 |
£1100 |
10.5 % |
United Kingdom Anesthesia & Respiratory Device Investment Opportunity
Analysis & Forecasts to 2012
|
August 2008 |
£1495 |
10.5 % |
World’s Top Ten Generic Companies
|
November 2005 |
£1999 |
10.5 % |
World Generic Market Report 2007
|
November 2006 |
£595 |
9.8 % |
Scrip R&D Databook 2006
|
January 2006 |
£1295 |
9.8 % |
Drug Delivery Technology: Revolutionizing Cardiovascular Therapies
|
July 2007 |
£945 |
9.5 % |
Strategies for Biogeneric Success
|
June 2004 |
£950 |
9.45 % |
Angiogenesis Modulators
|
January 2008 |
£1390 |
9.1 % |
Neurodegenerative Disease Drug Market Analysis and Forecasts 2007
|
June 2007 |
£1999 |
9 % |
China Orthopedic Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Joint Reconstruction, Spinal Surgery, Trauma Fixation, Orthobiologics, Diagnostic Devices, Equipment and Supplies
|
April 2008 |
£1515 |
8.4 % |
GE Healthcare Product Pipeline Analysis
|
May 2008 |
£380 |
8.4 % |
World market for cancer vaccines 2007-2012
|
January 2007 |
£1999 |
8.4 % |
Anti Infectives, Vol II: Antibacterials
|
April 2007 |
£1510 |
8.4 % |
Vaccines
|
March 2008 |
£600 |
8.4 % |
Malaysia: Country Scan
Country Scan
|
August 2006 |
£550 |
8.05 % |
Global Bulk Drugs Industry Report
|
August 2006 |
£550 |
8.05 % |
Generic League
Market Analysis and Forecasts, 2007-2012, 2017 & 2022
|
February 2008 |
£1999 |
7.7 % |
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023
|
June 2008 |
£1499 |
7.7 % |
Israel Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7 % |
World Biotech Market 2005, The
|
June 2005 |
£4999 |
7 % |
Pfizer - Market Outlook for a Global Leader, 2008-2013
|
August 2008 |
£0 |
6.65 % |
Japan Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.65 % |
Australia Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.65 % |
GSK's Cervarix
A Future Blockbuster of 2007
|
March 2007 |
£1999 |
6.65 % |
Germany Endoscopy Devices Investment Opportunities
Analysis and Forecasts to 2012
|
September 2008 |
£1625 |
6.3 % |
hERG Screening
|
January 2008 |
£1465 |
6.3 % |
Executive Guide to Molecular Imaging; The
|
April 2005 |
£395 |
6.3 % |
Global Generics Industry Report
|
September 2006 |
£550 |
6.3 % |
ADME/TOX Technologies
|
January 2008 |
£1450 |
6.3 % |
Indian Bulk Drug Industry Insight 2007
|
May 2007 |
£400 |
6.3 % |
Therapeutic Monoclonal Antibodies Report 2008-2023
|
July 2008 |
£0 |
5.95 % |
Top 10 Generic Pharmaceutical Companies, The
Positioning, Performance and SWOT Analyses
|
July 2008 |
£1995 |
5.95 % |
Global Market for Antimicrobials and Antifungals; The
Challenging Resistance to 2016
|
December 2006 |
£1600 |
5.6 % |
Patient Compliance Europe
|
August 2006 |
£75 |
5.6 % |
Epigenomics
Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics
|
March 2007 |
£2410 |
5.25 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
4.9 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
4.9 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
4.9 % |
Parkinson's Disease Market analysis and forecasts
2008-2012, 2017 & 2022
|
January 2008 |
£1499 |
4.9 % |
Stem Cell Research
|
January 2008 |
£2110 |
4.9 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
4.9 % |
Nuclear Cardiology Markets
|
December 2007 |
£1080 |
4.55 % |
RNA Interference Markets
|
September 2008 |
£1135 |
4.55 % |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2410 |
4.55 % |
Antiageing and Life Enhancement Pharmacotherapeutics
|
January 2006 |
£4600 |
4.2 % |
Online Pharmaceutical Industry, 2006-2011, The
|
July 2006 |
£1499 |
3.85 % |
The Executive Guide to Molecular Imaging
|
July 2007 |
£595 |
3.85 % |
New Trends in European Pharmacy
|
January 2001 |
£200 |
3.85 % |
In Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
2.8 % |
In-Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
2.8 % |
Cancer Therapeutics: The Worldwide Market
The Worldwide Market , 2nd Editon
|
February 2007 |
£2015 |
2.8 % |
|
|
|
|
